Top Gap Ups and Downs on Wednesday: MUFG, SMFG, DASH and More
NOV Cut to Sell Equivalent, Baker Hughes Raised to Buy at Wells Fargo
Express News | Nov, Inc. : Wells Fargo Cuts Target Price to $16 From $20
Express News | Nov, Inc. : Wells Fargo Cuts to Underweight From Equal Weight
Wells Fargo Maintains NOV Inc(NOV.US) With Sell Rating, Maintains Target Price $16
Wells Fargo Downgrades NOV Inc(NOV.US) to Sell Rating, Cuts Target Price to $16
Overweight Quality Stocks With Positive EPS Revision - MS
Press Release: NOV Announces Third Quarter 2024 Earnings Conference Call
NOV Inc. (NYSE:NOV) Shares Could Be 48% Below Their Intrinsic Value Estimate
Peeling Back The Layers: Exploring NOV Through Analyst Insights
NOV Is Maintained at Overweight by Morgan Stanley
NOV Analyst Ratings
Morgan Stanley Maintains NOV Inc(NOV.US) With Buy Rating, Cuts Target Price to $23
Express News | Nov Inc: Terminated Credit Agreement Dated June 27, 2017 With Syndicate of Lenders
Express News | Nov Inc: 2024 Facility Has Initial Maturity of Sept 2029
Express News | Nov Inc: Entered Into Credit Agreement Evidencing 5-Year Unsecured Revolving Credit Facility
Further Weakness as NOV (NYSE:NOV) Drops 5.8% This Week, Taking Five-year Losses to 28%
Nov Inc. (NOV) Is a Top-Ranked Growth Stock: Should You Buy?
Investors in NOV (NYSE:NOV) Have Seen Decent Returns of 42% Over the Past Three Years
NOV Inc. (NYSE:NOV) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?